AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
65 hedge funds and large institutions have $57.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
49% more call options, than puts
Call options by funds: $8.43M | Put options by funds: $5.65M
Holders
65
Holding in Top 10
–
Calls
$8.43M
Puts
$5.65M
Top Buyers
| 1 | +$7.36M | |
| 2 | +$6.95M | |
| 3 | +$3.29M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.22M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.98M |
Top Sellers
| 1 | -$296K | |
| 2 | -$128K | |
| 3 | -$128K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$107K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$52.9K |